Evidence map›Paper›PMID 35975975›Full record

ArticleeLife2022

Aminomethanesulfonic acid illuminates the boundary between full and partial agonists of the pentameric glycine receptor.

Josip Ivica, Hongtao Zhu, Remigijus Lape, Eric Gouaux, Lucia G Sivilotti

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Exploring the Activation Process of the Glycine Receptor.Journal of the American Chemical Society · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 4 countries.

Josip Ivica *Department of Neuroscience, Physiology and Pharmacology, Division of Biosciences, University College London, London, United Kingdom.
Hongtao Zhu *Vollum Institute, Oregon Health and Science University, Portland, United States.ORCID 0000-0003-1522-0500
Remigijus LapeDepartment of Neuroscience, Physiology and Pharmacology, Division of Biosciences, University College London, London, United Kingdom.
Eric GouauxVollum Institute, Oregon Health and Science University, Portland, United States.ORCID 0000-0002-8549-2360
Lucia G SivilottiDepartment of Neuroscience, Physiology and Pharmacology, Division of Biosciences, University College London, London, United Kingdom.ORCID 0000-0003-2510-8424
University College London · GBHoward Hughes Medical Institute · USOregon Health & Science University · US

Funding

Structural biology of neurotransmitter ion channelsR01GM100400 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOUAUX, JAMES E · 2012 to 2020
$2.3M
Medical Research Council MR/R009074/1NIGMS NIH HHS R01 GM100400
6 · The paper itself

Abstract

To clarify the determinants of agonist efficacy in pentameric ligand-gated ion channels, we examined a new compound, aminomethanesulfonic acid (AMS), a molecule intermediate in structure between glycine and taurine. Despite wide availability, to date there are no reports of AMS action on glycine receptors, perhaps because AMS is unstable at physiological pH. Here, we show that at pH 5, AMS is an efficacious agonist, eliciting in zebrafish α1 glycine receptors a maximum single-channel open probability of 0.85, much greater than that of β-alanine (0.54) or taurine (0.12), and second only to that of glycine itself (0.96). Thermodynamic cycle analysis of the efficacy of these closely related agonists shows supra-additive interaction between changes in the length of the agonist molecule and the size of the anionic moiety. Single particle cryo-electron microscopy structures of AMS-bound glycine receptors show that the AMS-bound agonist pocket is as compact as with glycine, and three-dimensional classification demonstrates that the channel populates the open and the desensitized states, like glycine, but not the closed intermediate state associated with the weaker partial agonists, β-alanine and taurine. Because AMS is on the cusp between full and partial agonists, it provides a new tool to help us understand agonist action in the pentameric superfamily of ligand-gated ion channels.

Indexed as

Receptors, GlycineZebrafishAnimalsbeta-AlanineCryoelectron MicroscopyGlycineSulfonic AcidsTaurineaminomethanesulfonic acidbeta-AlanineGlycineReceptors, GlycineSulfonic AcidsTaurineagonistscryoEMglycine receptorsmolecular biophysicssingle channel recordingstructural biologyzebrafish

Identifiers

PMID35975975
PMCPMC9462852
OpenAlexW4292092811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.